A Leading Location
The German capital region provides outstanding potential for development and ideal conditions for the biotechnology and pharmaceuticals industry. Its major strengths are a unique research landscape and a close network of the players along the entire value-added chain. Its many technology parks and networks in various fields of modern biotechnology provide an excellent infrastructure and form the technological backbone of the biotechnology and pharmaceuticals industry in Berlin and Brandenburg.
Are you planning on developing your company’s presence in the German capital? A good choice! We will help you implement your decision to locate or expand your company in Berlin-Brandenburg.
AudioCure Pharma GmbH secures funding of about EUR 9 million for the further development of their lead candidate, AC102, in hearing loss
AudioCure, a pharmaceutical R&D company headquartered in Germany, announces today that it has secured an A-round of about EUR 9 million from MED-EL, HTGF and private investors. MED-EL receives exclusive licensing rights and...
Every year around mid-November, the international medical technology community gathers at MEDICA and Compamed in Düsseldorf. Naturally, the cluster HealthCapital was present with two joint booths in halls 15 and 3, featuring 44...
Venturing into one of the new big topics in RNA biology, the circRTrain network of eight scientific experts from Europe and Israel will be coordinated by Nikolaus Rajewsky, MDC, BIMSB. 15 PhD candidates will be trained in...
Unfortunately many experiments are designed with avoidable flaws and it is only rarely that statistical analysis can rescue the experimenter. Our course provides you with comprehensive input for the basics and selected tools for...
Join the first HealthCapital Meetup hosted by welldoo
The 8th Purchasing Congress of German hospitals will take place on 8th and 9th December 2016.